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ABSTRACT 
The cytotoxic and genotoxic effects of goniothalamin, a plant styryllactone, were evaluated 
using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay 
and the Alkaline Comet assay respectively in human leukemic cell lines. Following 72 h of 
treatment, the IC50 values of goniothalamin in human HL-60 promyelocytic leukemia cells 
and CEM-SS T-lymphoblastic cells were 4.5 μg/mL and 2.4 μg/mL respectively. The 
genotoxicity of goniothalamin in both HL-60 and CEM-SS cells was detected as early as 2 h 
following treatment at IC10 and IC25 concentrations. However, pretreatment with the 
antioxidant N-acetyl-cysteine (NAC) at 1 mM for 30 minutes did not abrogate genotoxicity 
of this compound. This result suggests that primary induction of DNA damage by 
goniothalamin may not involve oxidative damage. In conclusion, our results demonstrate 
genotoxic damage induced by goniothalamin in leukemic cells. Further studies are needed to 
ascertain the mode of action of goniothalamin in inducing DNA damage. 
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